MET
MetLife, Inc. NYSE Listed Apr 5, 2000$85.58
-0.31%
vs $85.85
Mkt Cap $55.1B
52w Low $67.33
81.9% of range
52w High $89.62
50d MA $80.81
200d MA $78.18
P/E (TTM)
17.8x
EV/EBITDA
-8.7x
P/B
2.0x
Debt/Equity
0.7x
ROE
11.9%
P/FCF
3.1x
RSI (14)
59.60
ATR (14)
$1.77
Beta
0.73
50d MA
$80.81
200d MA
$78.18
Avg Volume
3.8M
MetLife, Inc., a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through five segments: U.S.; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements. It also provides pension risk transfers, institutional income annuities, structured settlements, and capital markets investment products; and other products and services, such as life insurance products and funding agreements for funding postretirement benefits, as well as company, bank, or trust-owned life insurance used to finance nonqualified benefit programs for executives. In addition, it provides fixed, indexed-linked, and variable annuities; and pension products; regular savings products; whole and term life, endowments, universal and variable life, and group life products; longevity reinsurance solutions; credit insurance products; and protection against long-term health care services. MetLife, Inc. was founded in 1863 and is headquartered in New York, New York.
200 Park Avenue · New York City, NY 10166-0188 · US
| Date | Time | Est | Rptd | Surp | Base | Gap% | D1% | D2% | D3% | D4% | D5% | Guide ▲★ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| May 6, 2026 | AMC | 2.27 | 2.42 | +6.6% | 80.16 | +0.5% | -1.7% | -0.9% | -0.1% | +0.8% | -0.7% | — |
| Feb 4, 2026 | AMC | 2.34 | 2.58 | +10.3% | 78.01 | +1.9% | -3.4% | +1.4% | -0.1% | +2.1% | +1.2% | — |
| Nov 5, 2025 | AMC | 2.31 | 2.34 | +1.3% | 78.68 | +1.0% | -3.4% | +0.2% | +1.4% | +0.8% | +3.1% | — |
| Aug 6, 2025 | AMC | 2.15 | 2.02 | -6.0% | 75.95 | -5.1% | -2.8% | +3.3% | -1.3% | +1.7% | +1.0% | — |
| Apr 30, 2025 | AMC | 2.00 | 1.96 | -2.0% | 75.37 | +1.3% | +0.5% | +2.7% | -0.5% | -1.3% | +0.4% | — |
| Feb 5, 2025 | AMC | 2.11 | 2.08 | -1.4% | 85.00 | -2.0% | -1.6% | +0.3% | -1.0% | +0.1% | -0.5% | — |
| Oct 30, 2024 | AMC | 2.17 | 1.95 | -10.1% | 83.18 | -7.9% | -5.7% | +0.0% | +0.2% | -0.5% | +6.5% | — |
| Jul 31, 2024 | AMC | 2.10 | 2.28 | +8.6% | 76.85 | +2.3% | -1.4% | -6.9% | -3.7% | +0.9% | +0.2% | — |
| May 1, 2024 | AMC | 1.84 | 1.83 | -0.5% | 71.88 | +0.7% | -2.3% | +0.4% | +1.0% | +0.1% | +0.6% | — |
| Jan 31, 2024 | AMC | 1.88 | 1.93 | +2.7% | 69.32 | -4.6% | -5.7% | +0.9% | -0.2% | +0.2% | +1.6% | — |
| Nov 1, 2023 | AMC | 1.99 | 1.97 | -1.0% | 59.98 | +0.0% | +0.1% | +2.9% | -2.2% | -0.6% | -1.2% | — |
| Aug 2, 2023 | AMC | 1.85 | 1.94 | +4.9% | 62.75 | +1.2% | +2.7% | -1.4% | +1.0% | -1.1% | -1.4% | — |
| May 3, 2023 | AMC | 1.85 | 1.52 | -17.8% | 58.71 | -1.1% | -7.8% | +1.0% | -1.8% | -1.7% | -1.8% | — |
| Date | Firm | Action | Grade | Target | Base | Open | Gap% | D1% | D2% | D3% | D4% | D5% |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Apr 14 | BofA Securities | Maintains | Buy → Buy | — | $75.36 | $75.41 | +0.1% | +0.9% | +1.9% | -0.6% | +1.3% | -0.5% |
| Apr 13 | Mizuho | Maintains | Outperform → Outperform | — | $73.88 | $73.22 | -0.9% | +2.0% | +0.9% | +1.9% | -0.6% | +1.3% |
| Apr 10 | Wells Fargo | Maintains | Overweight → Overweight | — | $74.65 | $74.61 | -0.1% | -1.0% | +2.0% | +0.9% | +1.9% | -0.6% |
| Apr 9 | UBS | Maintains | Buy → Buy | — | $74.34 | $73.78 | -0.8% | +0.4% | -1.0% | +2.0% | +0.9% | +1.9% |
| Apr 9 | Evercore ISI | Maintains | In Line → In Line | — | $74.34 | $73.78 | -0.8% | +0.4% | -1.0% | +2.0% | +0.9% | +1.9% |
| Apr 8 | Barclays | Maintains | Overweight → Overweight | — | $71.20 | $73.20 | +2.8% | +4.4% | +0.4% | -1.0% | +2.0% | +0.9% |
| Mar 11 | TD Cowen | Maintains | Buy → Buy | — | $70.60 | $70.73 | +0.2% | -0.9% | -1.7% | -1.2% | +1.8% | +0.2% |
| Mar 3 | Morgan Stanley | Maintains | Overweight → Overweight | — | $73.24 | $71.98 | -1.7% | -0.8% | +0.9% | -0.5% | -1.5% | -1.5% |
| Feb 25 | Wells Fargo | Maintains | Overweight → Overweight | — | $75.34 | $75.80 | +0.6% | -0.0% | +0.8% | -5.1% | +1.6% | -0.8% |
| Feb 11 | Evercore ISI | Maintains | In Line → In Line | — | $77.92 | $77.95 | +0.0% | +1.2% | -1.9% | -0.1% | +1.6% | +0.8% |
| Feb 5 | UBS | Maintains | Buy → Buy | — | $78.01 | $79.50 | +1.9% | -3.4% | +1.4% | -0.1% | +2.1% | +1.2% |
| Jan 13 | Wells Fargo | Maintains | Overweight → Overweight | — | $78.32 | $78.18 | -0.2% | -1.6% | +2.0% | -1.0% | -1.5% | -1.6% |
| Jan 8 | UBS | Maintains | Buy → Buy | — | $78.27 | $78.39 | +0.2% | +1.9% | -0.5% | -1.4% | -1.6% | +2.0% |
| Dec 23 | Wells Fargo | Maintains | Overweight → Overweight | — | $81.35 | $81.34 | -0.0% | -0.5% | +0.2% | -0.9% | -0.4% | -0.3% |
| Nov 11 | Keefe, Bruyette & Woods | Maintains | Outperform → Outperform | — | $77.18 | $77.41 | +0.3% | +0.8% | +3.1% | -0.9% | -1.0% | -4.0% |
| Nov 7 | Wells Fargo | Maintains | Overweight → Overweight | — | $75.97 | $75.39 | -0.8% | +0.2% | +1.4% | +0.8% | +3.1% | -0.9% |
| Nov 6 | UBS | Maintains | Buy → Buy | — | $78.68 | $79.50 | +1.0% | -3.4% | +0.2% | +1.4% | +0.8% | +3.1% |
| Nov 6 | BofA Securities | Maintains | Buy → Buy | — | $78.68 | $79.50 | +1.0% | -3.4% | +0.2% | +1.4% | +0.8% | +3.1% |
| Oct 13 | BofA Securities | Maintains | Buy → Buy | — | $79.77 | $80.73 | +1.2% | +1.3% | +2.6% | -1.5% | -4.6% | +0.8% |
| Oct 8 | Barclays | Maintains | Overweight → Overweight | — | $82.75 | $83.38 | +0.8% | -0.9% | -0.1% | -2.7% | +1.3% | +2.6% |
| Oct 8 | Wells Fargo | Maintains | Overweight → Overweight | — | $82.75 | $83.38 | +0.8% | -0.9% | -0.1% | -2.7% | +1.3% | +2.6% |
| Oct 7 | Morgan Stanley | Maintains | Overweight → Overweight | — | $82.35 | $82.78 | +0.5% | +0.5% | -0.9% | -0.1% | -2.7% | +1.3% |
| Sep 19 | Piper Sandler | Downgrade | Overweight → Neutral | — | $79.07 | $78.92 | -0.2% | +0.1% | +2.3% | -0.8% | +0.4% | -0.4% |
| Aug 18 | Morgan Stanley | Maintains | Overweight → Overweight | — | $77.33 | $76.90 | -0.6% | +0.5% | +1.3% | +0.4% | +0.3% | +2.8% |
| Aug 11 | Keefe, Bruyette & Woods | Maintains | Outperform → Outperform | — | $76.27 | $76.36 | +0.1% | -1.3% | +1.7% | +1.0% | +0.7% | -0.8% |
| Aug 11 | Jefferies | Maintains | Buy → Buy | — | $76.27 | $76.36 | +0.1% | -1.3% | +1.7% | +1.0% | +0.7% | -0.8% |
| Aug 7 | UBS | Maintains | Buy → Buy | — | $75.95 | $72.10 | -5.1% | -2.8% | +3.3% | -1.3% | +1.7% | +1.0% |
| Jul 14 | Morgan Stanley | Maintains | Overweight → Overweight | — | $77.70 | $77.44 | -0.3% | +0.3% | -2.2% | +0.5% | +1.0% | -0.2% |
| Jul 10 | Wells Fargo | Maintains | Overweight → Overweight | — | $78.24 | $78.28 | +0.1% | +0.2% | -0.9% | +0.3% | -2.2% | +0.5% |
| Jul 9 | Keefe, Bruyette & Woods | Maintains | Outperform → Outperform | — | $79.66 | $79.94 | +0.4% | -1.8% | +0.2% | -0.9% | +0.3% | -2.2% |
| Jul 8 | JP Morgan | Maintains | Overweight → Overweight | — | $79.18 | $79.49 | +0.4% | +0.6% | -1.8% | +0.2% | -0.9% | +0.3% |
| Jul 7 | Barclays | Maintains | Overweight → Overweight | — | $80.65 | $80.40 | -0.3% | -1.8% | +0.6% | -1.8% | +0.2% | -0.9% |
| May 19 | Morgan Stanley | Maintains | Overweight → Overweight | — | $80.83 | $80.30 | -0.7% | +0.0% | -0.7% | -3.0% | -0.3% | -0.6% |
| May 6 | Wells Fargo | Maintains | Overweight → Overweight | — | $77.41 | $76.29 | -1.4% | -1.3% | +0.4% | +1.1% | +0.3% | +3.6% |
| Apr 11 | Barclays | Maintains | Overweight → Overweight | — | $71.11 | $70.74 | -0.5% | +0.4% | +2.2% | -0.3% | -1.4% | +1.2% |
| Apr 10 | Morgan Stanley | Maintains | Overweight → Overweight | — | $75.24 | $73.17 | -2.8% | -5.5% | +0.4% | +2.2% | -0.3% | -1.4% |
| Apr 10 | Wells Fargo | Maintains | Overweight → Overweight | — | $75.24 | $73.17 | -2.8% | -5.5% | +0.4% | +2.2% | -0.3% | -1.4% |
| Apr 9 | Keefe, Bruyette & Woods | Maintains | Outperform → Outperform | — | $68.42 | $67.89 | -0.8% | +10.0% | -5.5% | +0.4% | +2.2% | -0.3% |
| Apr 2 | UBS | Maintains | Buy → Buy | — | $81.16 | $79.80 | -1.7% | +1.6% | -8.0% | -9.0% | +0.4% | -1.3% |
| Apr 2 | JP Morgan | Maintains | Overweight → Overweight | — | $81.16 | $79.80 | -1.7% | +1.6% | -8.0% | -9.0% | +0.4% | -1.3% |
| Apr 2 | Piper Sandler | Maintains | Overweight → Overweight | — | $81.16 | $79.80 | -1.7% | +1.6% | -8.0% | -9.0% | +0.4% | -1.3% |
| Feb 28 | Morgan Stanley | Maintains | Overweight → Overweight | — | $84.05 | $84.79 | +0.9% | +2.5% | -0.6% | -4.8% | +1.8% | -1.0% |
| Feb 19 | Wells Fargo | Maintains | Overweight → Overweight | — | $82.43 | $82.03 | -0.5% | +0.8% | -0.4% | -2.1% | +0.2% | +1.2% |
| Feb 12 | Keefe, Bruyette & Woods | Maintains | Outperform → Outperform | — | $83.17 | $82.60 | -0.7% | -0.5% | -0.5% | -0.8% | +0.9% | +0.8% |
| Feb 7 | Barclays | Maintains | Overweight → Overweight | — | $83.67 | $83.84 | +0.2% | +0.3% | -1.0% | +0.1% | -0.5% | -0.5% |
| Jan 14 | Wells Fargo | Maintains | Overweight → Overweight | — | $81.91 | $82.00 | +0.1% | +2.3% | +1.3% | +1.1% | +1.0% | +0.1% |
| Jan 7 | JP Morgan | Maintains | Overweight → Overweight | — | $81.99 | $82.50 | +0.6% | +0.2% | +0.8% | -3.1% | +2.1% | +2.3% |
| Jan 6 | Barclays | Maintains | Overweight → Overweight | — | $82.21 | $82.57 | +0.4% | -0.3% | +0.2% | +0.8% | -3.1% | +2.1% |
| Nov 27 | TD Cowen | Maintains | Buy → Buy | — | $87.76 | $87.87 | +0.1% | +0.6% | -0.0% | -1.5% | -1.3% | -0.4% |
| Nov 5 | Wells Fargo | Maintains | Overweight → Overweight | — | $78.56 | $78.16 | -0.5% | -0.5% | +6.5% | -2.7% | +0.0% | +0.9% |
| Date | Insider | Title | Type | Shares | Price | Value | Owned After | D1% | D5% |
|---|---|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | DEBEL MARLENEOff | EVP & Chief Risk Officer | Sell | 21,312 | $81.59 | $1.7M | 154,380 | +3.09% | +0.65% |
8-K
MetLife, Inc. -- 8-K Filing
MetLife confirmed its Q1 2026 dividend of $0.315 per share on its Series A preferred stock, maintaining consistent distributions to preferred shareholders.
Mar 5
8-K
MetLife, Inc. -- 8-K Filing
MetLife priced a debenture offering underwritten by major banks including Barclays, BofA Securities, Citigroup, Goldman Sachs, and Wells Fargo to raise capital through debt financing.
Feb 26
8-K
MetLife, Inc. -- 8-K Filing
I appreciate your submission, but I cannot provide analysis of this filing. The summary provided doesn't contain substantive information about a specific corporate event or transaction—it only describes filing classification mechanics. Please provide a summary with details about actual business developments.
Feb 24
8-K
MetLife, Inc. -- 8-K Filing
MetLife declared quarterly dividends on three preferred stock series (5.625% Series E, 4.75% Series F, and floating rate Series A), with Series A dividend subject to financial test confirmation.
Feb 17
8-K · 8.01
!! High
MetLife, Inc. -- 8-K 8.01: Material Event / Announcement
MetLife furnished earnings presentation materials to investors without filing them formally, indicating the company held an earnings call to discuss financial results and asset management metrics.
Feb 4
Institutional (13F) — Top 20
All ↗
| # | Manager | Shares | Value | Chg | Period |
|---|---|---|---|---|---|
| 1 | Dodge & Cox | 51,114,776 | $3.6B | Reduced | Mar 2026 |
| 2 | Vanguard Capital Management Llc | 35,856,817 | $2.5B | New | Mar 2026 |
| 3 | Vanguard Portfolio Management Llc | 30,813,441 | $2.2B | New | Mar 2026 |
| 4 | Morgan Stanley | 21,877,730 | $1.7B | Reduced | Dec 2025 |
| 5 | Pzena Investment Management Llc | 11,303,819 | $799M | Reduced | Mar 2026 |
| 6 | Invesco Ltd. | 6,919,363 | $489M | Reduced | Mar 2026 |
| 7 | Northern Trust Corp | 6,337,820 | $448M | Reduced | Mar 2026 |
| 8 | Bank Of America Corp /de/ | 5,499,868 | $389M | Reduced | Mar 2026 |
| 9 | Clearbridge Investments, Llc | 5,149,999 | $364M | Reduced | Mar 2026 |
| 10 | Nordea Investment Management Ab | 4,791,253 | $329M | Added | Mar 2026 |
| 11 | Diamond Hill Capital Management Inc | 3,631,783 | $287M | Reduced | Dec 2025 |
| 12 | Ubs Group Ag | 3,605,168 | $255M | Added | Mar 2026 |
| 13 | Aqr Capital Management Llc | 3,645,630 | $254M | Added | Mar 2026 |
| 14 | Bank Of New York Mellon Corp | 3,576,785 | $253M | Reduced | Mar 2026 |
| 15 | Jennison Associates Llc | 3,102,885 | $245M | Reduced | Dec 2025 |
| 16 | Jpmorgan Chase & Co | 3,427,700 | $234M | Reduced | Mar 2026 |
| 17 | Arrowstreet Capital, Limited Partnership | 3,098,649 | $219M | Added | Mar 2026 |
| 18 | Swedbank Ab | 2,702,087 | $191M | Added | Mar 2026 |
| 19 | Royal Bank Of Canada | 2,671,428 | $189M | Reduced | Mar 2026 |
| 20 | Amundi | 2,559,946 | $181M | New | Mar 2026 |
Mutual Funds / ETFs (N-PORT) — Top 20
All ↗
Valuation
Market Cap
$55.07B
Enterprise Value
-$49.81B
P/E (TTM)
17.83x
Forward P/E
8.74x
PEG Ratio
-0.79x
P/B
1.97x
P/S
0.74x
P/FCF
3.14x
EV/EBITDA
-8.71x
Shares Out
665.0M
Financials (TTM)
Revenue
$77.08B
Net Income
$3.38B
EBITDA
$5.72B
Free Cash Flow
$18.11B
Op Cash Flow
$18.11B
EPS Basic
$4.80
EPS Diluted
$4.80
EPS Forward
$9.79
Gross Margin
36.4%
Op Margin
6.0%
Net Margin
4.4%
Balance Sheet
Total Assets
$745.17B
Total Liab.
$716.25B
Total Equity
$28.92B
Cash
$125.34B
LT Debt
$18.62B
Book Value/Sh
$43.49
Debt/Equity
0.71x
Current Ratio
0.65
Quick Ratio
0.65
Returns & Growth
ROE
11.9%
ROA
0.4%
ROIC
0.7%
Rev Growth YoY
+10.2%
EPS Growth YoY
-19.7%
Price Returns
2W
+4.4%
1M
+3.2%
3M
+14.7%
6M
+8.0%
12M
+5.2%
Technicals
52W High
$89.62
52W Low
$67.33
50d MA
$80.81
200d MA
$78.18
RSI (14)
59.60
ATR (14)
$1.77
Beta
0.73
Avg Volume
3.8M
Dividends
Div Rate
$2.56
Div Yield
3.2%
Frequency
4
Ex-Div Date
Feb 3, 2026
Analyst Price Targets
Consensus
$96.50
High
$102.00
Low
$90.00
Median
$96.50
Data updated apr 26, 2026 11:54am
· Source: financialmodelingprep.com